<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">JAMA Netw Open</journal-id><journal-id journal-id-type="iso-abbrev">JAMA Netw Open</journal-id><journal-id journal-id-type="pmc-domain-id">3211</journal-id><journal-id journal-id-type="pmc-domain">jamasd</journal-id><journal-title-group><journal-title>JAMA Network Open</journal-title></journal-title-group><issn pub-type="epub">2574-3805</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>JAMA Network</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10407683</article-id><article-id pub-id-type="pmcid-ver">PMC10407683.1</article-id><article-id pub-id-type="pmcaid">10407683</article-id><article-id pub-id-type="pmcaiid">10407683</article-id><article-id pub-id-type="pmid">37548980</article-id><article-id pub-id-type="doi">10.1001/jamanetworkopen.2023.27363</article-id><article-id pub-id-type="publisher-id">zld230143</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="category" specific-use="electronic"><subject>Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Letter</subject></subj-group><subj-group subj-group-type="online-only"><subject>Online Only</subject></subj-group><subj-group subj-group-type="subject-area"><subject>Oncology</subject></subj-group></article-categories><title-group><article-title>Estimating Pack-Year Eligibility for Lung Cancer Screening Using 2 Yes or No Questions</article-title><alt-title alt-title-type="headline">Estimating Pack-Year Eligibility for Lung Cancer Screening</alt-title><alt-title alt-title-type="running-head">Estimating Pack-Year Eligibility for Lung Cancer Screening</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Rendle</surname><given-names initials="KA">Katharine A.</given-names></name><degrees>PhD</degrees><degrees>MSW</degrees><degrees>MPH</degrees><xref rid="zld230143aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="zld230143aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Steltz</surname><given-names initials="JP">Jennifer P.</given-names></name><degrees>MRA</degrees><xref rid="zld230143aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="zld230143aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cohen</surname><given-names initials="S">Sarah</given-names></name><degrees>MPH</degrees><xref rid="zld230143aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="zld230143aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Schapira</surname><given-names initials="MM">Marilyn M.</given-names></name><degrees>MD</degrees><degrees>MPH</degrees><xref rid="zld230143aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wender</surname><given-names initials="RC">Richard C.</given-names></name><degrees>MD</degrees><xref rid="zld230143aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bekelman</surname><given-names initials="JE">Justin E.</given-names></name><degrees>MD</degrees><xref rid="zld230143aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="zld230143aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Vachani</surname><given-names initials="A">Anil</given-names></name><degrees>MD</degrees><degrees>MS</degrees><xref rid="zld230143aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="zld230143aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="zld230143aff6" ref-type="aff">
<sup>6</sup>
</xref></contrib></contrib-group><aff id="zld230143aff1"><label>1</label>Department of Family Medicine &amp; Community Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia</aff><aff id="zld230143aff2"><label>2</label>Penn Center for Cancer Care Innovation, Abramson Cancer Center, Philadelphia, Pennsylvania</aff><aff id="zld230143aff3"><label>3</label>Division of Pulmonary and Critical Care, University of Pennsylvania School of Medicine, Philadelphia</aff><aff id="zld230143aff4"><label>4</label>Department of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia</aff><aff id="zld230143aff5"><label>5</label>Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia</aff><aff id="zld230143aff6"><label>6</label>Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania</aff><author-notes><title>Article Information</title><p><bold>Accepted for Publication:</bold> June 26, 2023.</p><p content-type="published-online"><bold>Published:</bold> August 7, 2023. doi:<uri content-type="doi">10.1001/jamanetworkopen.2023.27363</uri></p><p content-type="open-access-note"><bold>Open Access:</bold> This is an open access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://jamanetwork.com/pages/cc-by-license-permissions" ext-link-type="uri">CC-BY License</ext-link>. &#169; 2023 Rendle KA et al. <italic toggle="yes">JAMA Network Open</italic>.</p><corresp id="zld230143cor1"><bold>Corresponding Author:</bold> Katharine A. Rendle, PhD, MSW, MPH, Department of Family Medicine &amp; Community Health, Perelman School of Medicine, University of Pennsylvania, 3600 Civic Center Blvd, Philadelphia, PA 19104 (<email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="katharine.rendle@pennmedicine.upenn.edu">katharine.rendle@pennmedicine.upenn.edu</email>).</corresp><p content-type="author-contributions"><bold>Author Contributions:</bold> Dr Rendle had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.</p><p><italic toggle="yes">Concept and design:</italic> Rendle, Wender.</p><p><italic toggle="yes">Acquisition, analysis, or interpretation of data:</italic> Rendle, Steltz, Cohen, Schapira, Bekelman, Vachani.</p><p><italic toggle="yes">Drafting of the manuscript:</italic> Rendle, Schapira.</p><p><italic toggle="yes">Critical review of the manuscript for important intellectual content:</italic> All authors.</p><p><italic toggle="yes">Statistical analysis:</italic> Rendle, Cohen, Bekelman.</p><p><italic toggle="yes">Obtained funding:</italic> Rendle, Vachani.</p><p><italic toggle="yes">Administrative, technical, or material support:</italic> Rendle, Steltz.</p><p><italic toggle="yes">Supervision:</italic> Vachani.</p><p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> Dr Rendle reported receiving and grants from Pfizer and AstraZeneca paid to her institution, personal fees from Merck for serving as a scientific consultant, and honoraria and travel paid as invited speaker from MJH Life Sciences outside the submitted work. Dr Schapira reported receiving nonfinancial support from University of Pennsylvania outside the submitted work. Dr Bekelman reported receiving personal fees from United Healthcare, Reimagine Care, Healthcare Foundry, and AstraZeneca; and grants from Loxo@Lilly, Gilead, and Emerson Collective outside the submitted work. Dr Vachani reported receiving grants from MagArray Inc, Precyte Inc, Optellum Ltd, Lungevity Foundation, the Gordon and Betty Moore Foundation, and grants from the National Comprehensive Cancer Network; and personal fees from Johnson and Johnson, outside the submitted work. No other disclosures were reported.</p><p content-type="funding-statement"><bold>Funding/Support:</bold> Research reported in this publication was supported by the funding from the National Cancer Institute under Award Numbers UM1CA221939 (multiple principal investigator: Dr Vachani), P50CA271338 (multiple principal investigators: Drs Bekelman, Rendle, and Vachani), and P30CA016520.</p><p><bold>Role of the Funder/Sponsor:</bold> The National Cancer Institute had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p><p><bold>Disclaimer:</bold> The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.</p><p><bold>Meeting Presentation:</bold> This article was presented at the International Cancer Screening Network Meeting; June 23, 2023; Torino, Italy.</p><p content-type="data-sharing-statement"><bold>Data Sharing Statement:</bold> See the <xref rid="note-ZLD230143-1-s" ref-type="supplementary-material">Supplement</xref>.</p></author-notes><pub-date pub-type="epub" iso-8601-date="2023-08-07T10:00"><day>7</day><month>8</month><year>2023</year></pub-date><pub-date pub-type="collection"><month>8</month><year>2023</year></pub-date><volume>6</volume><issue>8</issue><issue-id pub-id-type="pmc-issue-id">442699</issue-id><elocation-id>e2327363</elocation-id><history><date date-type="received"><day>3</day><month>3</month><year>2023</year></date><date date-type="accepted"><day>26</day><month>6</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>07</day><month>08</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>09</day><month>08</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-08-09 00:25:10.423"><day>09</day><month>08</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>Copyright 2023 Rendle KA et al. <italic toggle="yes">JAMA Network Open</italic>.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the CC-BY License.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jamanetwopen-e2327363.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf-version" xlink:href="jamanetwopen-e2327363.pdf">jamanetwopen-e2327363.pdf</self-uri><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="silverchair" xlink:href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.27363"/><abstract abstract-type="teaser" specific-use="electronic"><p>This cross-sectional study describes the development and testing the accuracy of using 2 yes or no questions to estimate pack-year eligibility for lung cancer screening.</p></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="H1-1-ZLD230143"><title>Introduction</title><p>Lung cancer screening (LCS) for adults at high risk reduces lung cancer mortality by 16% to 20%.<sup><xref rid="zld230143r1" ref-type="bibr">1</xref></sup> However, uptake of LCS remains low and unequal in the US.<sup><xref rid="zld230143r2" ref-type="bibr">2</xref>,<xref rid="zld230143r3" ref-type="bibr">3</xref></sup> LCS differs from other types of cancer screening because eligibility assessment requires evaluation of lifetime smoking intensity (ie, pack-years). Although tobacco use (ie, current, former, or never) is well captured, calculated pack-years are often missing or inaccurate in electronic medical records (EMRs).<sup><xref rid="zld230143r4" ref-type="bibr">4</xref></sup> Prior approaches to assessing pack-years have used open-ended questions, a format associated with increased respondent burden and lower response rates.<sup><xref rid="zld230143r5" ref-type="bibr">5</xref></sup> There is a need for tools that simplify pack-year assessment while maintaining accuracy.<sup><xref rid="zld230143r4" ref-type="bibr">4</xref></sup> In this cross-sectional study, we developed and tested the accuracy of using 2 yes or no questions to estimate pack-year eligibility for LCS.</p></sec><sec id="H1-2-ZLD230143"><title>Methods</title><p>This study, approved by the University of Pennsylvania institutional review board (IRB), was embedded within a parent pilot trial aimed at increasing LCS at a multisite academic health care system (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://classic.clinicaltrials.gov/ct2/show/NCT04612946" ext-link-type="uri">NCT04612946</ext-link>). The parent trial used EMR data to identify primary care patients aged 55 to 80 years with no history of LCS or lung cancer and listed as currently smoking from 2018 to 2020. Prior to trial enrollment, we invited identified patients to complete an LCS eligibility survey electronically or via telephone using a waiver of written consent approved by the University of Pennsylvania IRB because the research placed no more than minimal risk to the participants. The survey asked open-ended questions regarding total number of years and mean number of packs per day smoked to calculate pack-years. The survey also included the following 2 yes or no questions: (1) If you add up all the years when you regularly smoked cigarettes, have you smoked for 20 years or more of your life? (2) At any time in your life, did you regularly smoke 1 or more packs of cigarettes per day? We evaluated the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the questions to estimate eligibility (ie, 20 or more pack-years) using 2 classifications of a positive response: (1) liberal (yes to at least 1 question) and (2) restrictive (yes to both questions). We calculated 95% CIs using the Clopper-Pearson method, with a 2-sided <italic toggle="yes">P</italic>&#8201;&lt;&#8201;.05 considered statistically significant. Using the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.equator-network.org/reporting-guidelines/strobe/" ext-link-type="uri">STROBE</ext-link> reporting guideline, we report results overall and stratified by sex, age, and race and ethnicity as documented in the patient&#8217;s EMR (due to known racial and ethnic disparities in lung cancer). All analyses were performed using Stata, version 17 (StataCorp LP).</p></sec><sec id="H1-3-ZLD230143"><title>Results</title><p>Of 303 patients who completed the survey, 156 (51.5%) were aged 55 to 64 years, 176 (58.1%) were female, and 62 (20.5%) were Black or African American; 210 (69.3%) reported 20 or more pack-years (<xref rid="zld230143t1" ref-type="table">Table 1</xref>). Using the liberal classification (<xref rid="zld230143t2" ref-type="table">Table 2</xref>), the yes or no questions had 100% NPV and 100% sensitivity for estimating pack-year eligibility for LCS but lower specificity overall (18.3%) and within subgroups (range, 13.0%-25.6%). Overall specificity (79.6%) and PPV (90.5% [range within subgroups, 88.3%-92.8%]) increased using the restrictive classification, but sensitivity decreased (85.7%), particularly among adults aged 55 to 64 years (81.4%) or Black adults (75.6%).</p><table-wrap position="float" id="zld230143t1" orientation="portrait"><label>Table 1. </label><caption><title>Participant Characteristics</title></caption><table frame="hsides" rules="groups"><col width="69.37%" span="1"/><col width="30.63%" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Characteristic<xref rid="zld230143t1n1" ref-type="table-fn"><sup>a</sup></xref></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">No. (%) (N&#8201;=&#8201;303)</th></tr></thead><tbody><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Age group, y</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 55-64</td><td valign="top" align="left" rowspan="1" colspan="1">156 (51.5)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 65-74</td><td valign="top" align="left" rowspan="1" colspan="1">125 (41.3)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> &#8805;75</td><td valign="top" align="left" rowspan="1" colspan="1">22 (7.3)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Sex</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Female</td><td valign="top" align="left" rowspan="1" colspan="1">176 (58.1)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Male</td><td valign="top" align="left" rowspan="1" colspan="1">127 (41.9)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Race</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Asian</td><td valign="top" align="left" rowspan="1" colspan="1">1 (0.3)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Black or African American</td><td valign="top" align="left" rowspan="1" colspan="1">62 (20.5)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Native American</td><td valign="top" align="left" rowspan="1" colspan="1">1 (0.3)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Pacific Islander</td><td valign="top" align="left" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> White</td><td valign="top" align="left" rowspan="1" colspan="1">220 (72.6)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Other<xref rid="zld230143t1n2" ref-type="table-fn"><sup>b</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">13 (4.3)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Unknown</td><td valign="top" align="left" rowspan="1" colspan="1">6 (2.0)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Ethnicity</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Hispanic</td><td valign="top" align="left" rowspan="1" colspan="1">4 (1.3)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Non-Hispanic</td><td valign="top" align="left" rowspan="1" colspan="1">295 (97.4)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Unknown</td><td valign="top" align="left" rowspan="1" colspan="1">4 (1.3)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Tobacco use</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Currently smokes</td><td valign="top" align="left" rowspan="1" colspan="1">303 (100.0)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Smoking pack-years</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 30-39</td><td valign="top" align="left" rowspan="1" colspan="1">26 (8.6)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 40-49</td><td valign="top" align="left" rowspan="1" colspan="1">25 (8.3)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> &#8805;50</td><td valign="top" align="left" rowspan="1" colspan="1">27 (8.9)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Missing pack-years</td><td valign="top" align="left" rowspan="1" colspan="1">225 (74.3)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Smoking pack-years (self-reported in survey)<xref rid="zld230143t1n3" ref-type="table-fn"><sup>c</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> &lt;20</td><td valign="top" align="left" rowspan="1" colspan="1">93 (30.7)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 20-29</td><td valign="top" align="left" rowspan="1" colspan="1">35 (11.6)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 30-39</td><td valign="top" align="left" rowspan="1" colspan="1">46 (15.2)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 40-49</td><td valign="top" align="left" rowspan="1" colspan="1">53 (17.5)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> &#8805;50</td><td valign="top" align="left" rowspan="1" colspan="1">76 (25.1)</td></tr></tbody></table><table-wrap-foot><fn id="zld230143t1n1"><label>
<sup>a</sup>
</label><p>All patient data unless otherwise noted were taken from the patient&#8217;s medical record at the time of enrollment.</p></fn><fn id="zld230143t1n2"><label>
<sup>b</sup>
</label><p>Racial category is listed as &#8220;other&#8221; in the electronic medical record, and therefore no other information on patient race is available.</p></fn><fn id="zld230143t1n3"><label>
<sup>c</sup>
</label><p>Participants were asked to answer the following open-ended questions to calculate pack-years: (1) Thinking about when you first started smoking regularly, how many total years have you smoked cigarettes across your lifetime? (2) Across your lifetime (on average), how many cigarettes have you usually smoked each day? There are 20 cigarettes in a pack. Lifetime pack-years calculated by multiplying each participant&#8217;s responses to the 2 questions and dividing by 20 (the number of cigarettes in a pack).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="zld230143t2" orientation="portrait"><label>Table 2. </label><caption><title>Accuracy of Yes or No Questions for Estimating Pack-Year Eligibility for LCS<xref rid="zld230143t2n1" ref-type="table-fn"><sup>a</sup></xref></title></caption><table frame="hsides" rules="groups"><col width="17.03%" span="1"/><col width="11.11%" span="1"/><col width="11.11%" span="1"/><col width="11.11%" span="1"/><col width="11.87%" span="1"/><col width="11.69%" span="1"/><col width="12.66%" span="1"/><col width="13.42%" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Characteristic</th><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Overall (N&#8201;=&#8201;303)</th><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Age, y</th><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Biological sex</th><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Race</th></tr><tr><th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">&lt;65 (n&#8201;=&#8201;156)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">&#8805;65 (n&#8201;=&#8201;147)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Female (n&#8201;=&#8201;176)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Male (n&#8201;=&#8201;127)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Black (n&#8201;=&#8201;62)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">White (n&#8201;=&#8201;220)</th></tr></thead><tbody><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1">
<bold>Simplified yes or no questions</bold>
</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Yes, to both questions, No. (%)</td><td valign="top" align="left" rowspan="1" colspan="1">199 (65.7)</td><td valign="top" align="left" rowspan="1" colspan="1">94 (60.3)</td><td valign="top" align="left" rowspan="1" colspan="1">105 (71.4)</td><td valign="top" align="left" rowspan="1" colspan="1">116 (65.9)</td><td valign="top" align="left" rowspan="1" colspan="1">83 (65.4)</td><td valign="top" align="left" rowspan="1" colspan="1">35 (56.5)</td><td valign="top" align="left" rowspan="1" colspan="1">152 (69.1)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Yes, to only 1 question, No. (%)</td><td valign="top" align="left" rowspan="1" colspan="1">87 (28.7)</td><td valign="top" align="left" rowspan="1" colspan="1">55 (35.3)</td><td valign="top" align="left" rowspan="1" colspan="1">32 (21.8)</td><td valign="top" align="left" rowspan="1" colspan="1">53 (30.1)</td><td valign="top" align="left" rowspan="1" colspan="1">34 (26.8)</td><td valign="top" align="left" rowspan="1" colspan="1">24 (38.7)</td><td valign="top" align="left" rowspan="1" colspan="1">58 (26.4)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">No, to both, No. (%)</td><td valign="top" align="left" rowspan="1" colspan="1">17 (5.6)</td><td valign="top" align="left" rowspan="1" colspan="1">7 (4.5)</td><td valign="top" align="left" rowspan="1" colspan="1">10 (6.8)</td><td valign="top" align="left" rowspan="1" colspan="1">7 (4.0)</td><td valign="top" align="left" rowspan="1" colspan="1">10 (7.9)</td><td valign="top" align="left" rowspan="1" colspan="1">3 (4.8)</td><td valign="top" align="left" rowspan="1" colspan="1">10 (4.6)</td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1">
<bold>Calculated pack-years (open-ended questions)</bold>
</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">LCS eligible (&#8805;20 pack-years), No. (%)</td><td valign="top" align="left" rowspan="1" colspan="1">210 (69.3)</td><td valign="top" align="left" rowspan="1" colspan="1">102 (65.4)</td><td valign="top" align="left" rowspan="1" colspan="1">108 (73.5)</td><td valign="top" align="left" rowspan="1" colspan="1">123 (69.9)</td><td valign="top" align="left" rowspan="1" colspan="1">87 (68.5)</td><td valign="top" align="left" rowspan="1" colspan="1">41 (66.1)</td><td valign="top" align="left" rowspan="1" colspan="1">161 (73.2)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">LCS ineligible (&lt;20 pack-years), No. (%)</td><td valign="top" align="left" rowspan="1" colspan="1">93 (30.7)</td><td valign="top" align="left" rowspan="1" colspan="1">54 (34.6)</td><td valign="top" align="left" rowspan="1" colspan="1">39 (26.5)</td><td valign="top" align="left" rowspan="1" colspan="1">43 (24.4)</td><td valign="top" align="left" rowspan="1" colspan="1">40 (31.5)</td><td valign="top" align="left" rowspan="1" colspan="1">21 (33.9)</td><td valign="top" align="left" rowspan="1" colspan="1">59 (26.8)</td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1">
<bold>Accuracy using liberal classification: positive indicates yes to at least 1 question</bold>
</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sensitivity (95% CI), %</td><td valign="top" align="left" rowspan="1" colspan="1">100.0 (98.3-100.0)</td><td valign="top" align="left" rowspan="1" colspan="1">100.0 (96.5-100.0)</td><td valign="top" align="left" rowspan="1" colspan="1">100.0 (96.6-100.0)</td><td valign="top" align="left" rowspan="1" colspan="1">100.0 (97.0-100.0)</td><td valign="top" align="left" rowspan="1" colspan="1">100.0 (95.8-100.00)</td><td valign="top" align="left" rowspan="1" colspan="1">100.0 (91.4-100.0)</td><td valign="top" align="left" rowspan="1" colspan="1">100.0 (97.7-100.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Specificity (95% CI), %</td><td valign="top" align="left" rowspan="1" colspan="1">18.3 (11.7-27.5)</td><td valign="top" align="left" rowspan="1" colspan="1">13.0 (6.3-24.9)</td><td valign="top" align="left" rowspan="1" colspan="1">25.6 (14.3-41.6)</td><td valign="top" align="left" rowspan="1" colspan="1">13.2 (6.3-25.3)</td><td valign="top" align="left" rowspan="1" colspan="1">25.0 (13.9-40.7)</td><td valign="top" align="left" rowspan="1" colspan="1">14.3 (4.6-36.7)</td><td valign="top" align="left" rowspan="1" colspan="1">16.9 (9.3-28.8)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PPV (95% CI), %</td><td valign="top" align="left" rowspan="1" colspan="1">73.4 (68.0-78.2)</td><td valign="top" align="left" rowspan="1" colspan="1">68.5 (60.5-75.5)</td><td valign="top" align="left" rowspan="1" colspan="1">78.8 (71.1-84.9)</td><td valign="top" align="left" rowspan="1" colspan="1">72.8 (65.5-79.0)</td><td valign="top" align="left" rowspan="1" colspan="1">74.4 (65.6-81.5)</td><td valign="top" align="left" rowspan="1" colspan="1">69.5 (56.4-80.0)</td><td valign="top" align="left" rowspan="1" colspan="1">76.7 (70.4-81.9)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">NPV (95% CI), %</td><td valign="top" align="left" rowspan="1" colspan="1">100.0 (80.5-100.0)</td><td valign="top" align="left" rowspan="1" colspan="1">100.0 (59.0-100.0)</td><td valign="top" align="left" rowspan="1" colspan="1">100.0 (69.2-100.0)</td><td valign="top" align="left" rowspan="1" colspan="1">100.0 (59.0-100.0)</td><td valign="top" align="left" rowspan="1" colspan="1">100.0 (69.2-100.0)</td><td valign="top" align="left" rowspan="1" colspan="1">100.0 (29.2-100.0)</td><td valign="top" align="left" rowspan="1" colspan="1">100.0 (69.2-100.0)</td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1">
<bold>Accuracy using restrictive classification: positive indicates yes to both questions</bold>
</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sensitivity (95% CI), %</td><td valign="top" align="left" rowspan="1" colspan="1">85.7 (80.2-89.8)</td><td valign="top" align="left" rowspan="1" colspan="1">81.4 (72.6-87.9)</td><td valign="top" align="left" rowspan="1" colspan="1">89.8 (82.5-94.3)</td><td valign="top" align="left" rowspan="1" colspan="1">84.6 (77.0-90.0)</td><td valign="top" align="left" rowspan="1" colspan="1">87.4 (78.5-92.9)</td><td valign="top" align="left" rowspan="1" colspan="1">75.6 (60.0-86.5)</td><td valign="top" align="left" rowspan="1" colspan="1">87.6 (81.5-91.9)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Specificity (95% CI), %</td><td valign="top" align="left" rowspan="1" colspan="1">79.6 (70.1-86.6)</td><td valign="top" align="left" rowspan="1" colspan="1">79.6 (66.7-88.4)</td><td valign="top" align="left" rowspan="1" colspan="1">79.5 (63.9-89.5)</td><td valign="top" align="left" rowspan="1" colspan="1">77.4 (64.1%-86.7%)</td><td valign="top" align="left" rowspan="1" colspan="1">82.5 (67.4-91.5)</td><td valign="top" align="left" rowspan="1" colspan="1">81.0 (58.3-92.8)</td><td valign="top" align="left" rowspan="1" colspan="1">81.4 (69.3-89.4)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PPV (95% CI), %</td><td valign="top" align="left" rowspan="1" colspan="1">90.5 (85.5-93.8)</td><td valign="top" align="left" rowspan="1" colspan="1">88.3 (80.0-93.4)</td><td valign="top" align="left" rowspan="1" colspan="1">92.4 (85.4-96.2)</td><td valign="top" align="left" rowspan="1" colspan="1">89.7 (82.7-94.1)</td><td valign="top" align="left" rowspan="1" colspan="1">91.6 (83.2-96.0)</td><td valign="top" align="left" rowspan="1" colspan="1">88.6 (72.8-95.7)</td><td valign="top" align="left" rowspan="1" colspan="1">92.8 (87.4-96.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">NPV (95% CI), %</td><td valign="top" align="left" rowspan="1" colspan="1">71.2 (61.7-79.0)</td><td valign="top" align="left" rowspan="1" colspan="1">69.4 (56.8-79.6)</td><td valign="top" align="left" rowspan="1" colspan="1">73.8 (58.5-84.9)</td><td valign="top" align="left" rowspan="1" colspan="1">68.3 (55.5-78.9)</td><td valign="top" align="left" rowspan="1" colspan="1">75.0 (60.1-85.7)</td><td valign="top" align="left" rowspan="1" colspan="1">63.0 (43.4-79.0)</td><td valign="top" align="left" rowspan="1" colspan="1">70.6 (58.7-80.2)</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: LCS, lung cancer screening; NPV, negative predictive value; PPV, positive predictive value.</p><fn id="zld230143t2n1"><label>
<sup>a</sup>
</label><p>Age, sex, and race are as reported in the electronic medical record. For race, we limited comparison with the most common racial groups in our sample (Black adults vs White adults).</p></fn></table-wrap-foot></table-wrap></sec><sec id="H1-4-ZLD230143"><title>Discussion</title><p>Response to 2 yes or no questions showed high sensitivity for estimating pack-year eligibility for LCS, helping to identify pragmatic solutions for overcoming the challenge of assessing pack-years in routine practice.<sup><xref rid="zld230143r6" ref-type="bibr">6</xref></sup> We observed differences in sensitivity and specificity between liberal and restrictive classifications of positive response. However, these differences might also increase the range of utility of these questions in practice. The restrictive classification could be used to equitably identify patients for direct referral to shared decision-making for LCS given the high PPV overall (90.5%) and within each subgroup (88.3%-92.8%), whereas the liberal classification could be used to efficiently exclude patients from LCS outreach given the consistently high NPV (100.0%). Our study is limited by its sample size, single site, and exclusion of years since quitting among adults who formerly smoked. Future work, including testing in a larger national sample of participants aged 50 to 80 years, could expand on these findings.</p></sec></body><back><ref-list id="REF-ZLD230143"><title>References</title><ref id="zld230143r1"><label>1</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Field</surname><given-names>JK</given-names></string-name>, <string-name name-style="western"><surname>Vulkan</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Davies</surname><given-names>MPA</given-names></string-name>, <etal/></person-group>. <article-title>Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis</article-title>. <source>Lancet Reg Health Eur</source>. <year>2021</year>;<volume>10</volume>:<elocation-id>100179</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.lanepe.2021.100179</pub-id><pub-id pub-id-type="pmid">34806061</pub-id><pub-id pub-id-type="pmcid">PMC8589726</pub-id></mixed-citation></ref><ref id="zld230143r2"><label>2</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Fedewa</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Kazerooni</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Studts</surname><given-names>JL</given-names></string-name>, <etal/></person-group>. <article-title>State variation in low-dose computed tomography scanning for lung cancer screening in the United States</article-title>. <source>J Natl Cancer Inst</source>. <year>2021</year>;<volume>113</volume>(<issue>8</issue>):<fpage>1044</fpage>-<lpage>1052</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jnci/djaa170</pub-id><pub-id pub-id-type="pmid">33176362</pub-id><pub-id pub-id-type="pmcid">PMC8328984</pub-id></mixed-citation></ref><ref id="zld230143r3"><label>3</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Sakoda</surname><given-names>LC</given-names></string-name>, <string-name name-style="western"><surname>Rivera</surname><given-names>MP</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>J</given-names></string-name>, <etal/></person-group>. <article-title>Patterns and factors associated with adherence to lung cancer screening in diverse practice settings</article-title>. <source>JAMA Netw Open</source>. <year>2021</year>;<volume>4</volume>(<issue>4</issue>):<elocation-id>e218559</elocation-id>. doi:<pub-id pub-id-type="doi">10.1001/jamanetworkopen.2021.8559</pub-id><pub-id pub-id-type="pmid">33929519</pub-id><pub-id pub-id-type="pmcid">PMC8087957</pub-id></mixed-citation></ref><ref id="zld230143r4"><label>4</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Kukhareva</surname><given-names>PV</given-names></string-name>, <string-name name-style="western"><surname>Caverly</surname><given-names>TJ</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>H</given-names></string-name>, <etal/></person-group>. <article-title>Inaccuracies in electronic health records smoking data and a potential approach to address resulting underestimation in determining lung cancer screening eligibility</article-title>. <source>J Am Med Inform Assoc</source>. <year>2022</year>;<volume>29</volume>(<issue>5</issue>):<fpage>779</fpage>-<lpage>788</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jamia/ocac020</pub-id><pub-id pub-id-type="pmid">35167675</pub-id><pub-id pub-id-type="pmcid">PMC9006678</pub-id></mixed-citation></ref><ref id="zld230143r5"><label>5</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Millar</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Dillman</surname><given-names>D</given-names></string-name></person-group>. <article-title>Do mail and internet surveys produce different item nonresponse rates? an experiment using random mode assignment</article-title>. <source>Surv Pract</source>. <year>2012</year>;<volume>5</volume>(<issue>2</issue>):<fpage>1</fpage>-<lpage>7</lpage>. doi:<pub-id pub-id-type="doi">10.29115/SP-2012-0011</pub-id></mixed-citation></ref><ref id="zld230143r6"><label>6</label><mixed-citation publication-type="journal"><person-group><string-name name-style="western"><surname>Triplette</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Donovan</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Crothers</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Madtes</surname><given-names>DK</given-names></string-name>, <string-name name-style="western"><surname>Au</surname><given-names>DH</given-names></string-name></person-group>. <article-title>Prediction of lung cancer screening eligibility using simplified criteria</article-title>. <source>Ann Am Thorac Soc</source>. <year>2019</year>;<volume>16</volume>(<issue>10</issue>):<fpage>1280</fpage>-<lpage>1285</lpage>. doi:<pub-id pub-id-type="doi">10.1513/AnnalsATS.201903-239OC</pub-id><pub-id pub-id-type="pmid">31298946</pub-id></mixed-citation></ref></ref-list><notes notes-type="supplementary-material" id="note-ZLD230143-1"><supplementary-material id="note-ZLD230143-1-s" position="float" content-type="local-data" orientation="portrait"><label>Supplement.</label><caption><p>
Data Sharing Statement
</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jamanetwopen-e2327363-s001.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></notes></back></article></pmc-articleset>